Virtual Medicinal Product (VMP) - Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories

Name Details

Name Start Date End Date
Name Current Name Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories Start Date 01-12-2003 End Date
Previous Name Previous Name Zinc oxide 283.5mg / Lignocaine 13.2mg suppositories Start Date 12-02-2003 End Date 30-11-2003

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
suppository
Unit Dose UOM
suppository

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Rectal
Form
Suppository
Ontology Form/Route
suppository.rectal
Name Basis
Other

Codes

ATC Code
C05AX04
BNF Start Date End Date
Current BNF 01070100 Start Date 04-04-2022 End Date
Previous BNF 01070100 Start Date 04-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
3876111000001102 12-02-2003

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Lidocaine hydrochloride Based on Ingredient Substance 13.2 mg
Zinc oxide Based on Ingredient Substance 283.5 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
12 suppository 339 Part VIIIA Category C
24 suppository 566 Part VIIIA Category C